Anthony Cooper

Tony is a dedicated scientist and entrepreneur with a history of cross-disciplinary collaborative research focused on combining aspects from complementary fields to drive new value. Tony built collaborative projects among different labs both as a graduate student at the University of Chicago and as a postdoctoral research at The Scripps Research Institute. Upon making the transition to industry Tony began working at Adimab where he engineered and delivered over 1,000 potential therapeutic antibodies to partners. The programs that Tony led in his three years there have generated greater than $1.3B in upfront payments and have led to over a dozen patents in the US and abroad. Now, as co-founder and CEO of Aclys Bio, Tony seeks to leverage his broad knowledge base and build the next generation of antibody therapeutics specially tailored to Precision Oncology applications. In his free time Tony enjoys spending time with his family in and around the woods of Vermont.